Open AccessPneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review
Author(s) -
Е. И. Алексеева,
D. Vankova,
Margarita A. Soloshenko,
Т. М. Дворяковская,
К. Б. Исаева,
Р. В. Денисова,
A. Mamutova,
А.М. Чомахидзе,
Н. А. Маянский,
Н. Е. Ткаченко
Publication year - 2019
Publication title -
voprosy sovremennoj pediatrii
Language(s) - English
Resource type - Journals
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v18i2.2012
Subject(s) - medicine , arthritis , vaccination , pneumococcal disease , immunization , immunology , pneumococcal vaccine , disease , intensive care medicine , immune system , streptococcus pneumoniae , antibiotics , microbiology and biotechnology , biology
International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the adequate immune response after vaccination as well as alongside with genetically engineered biologic drugs therapy. Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications.